Domenica Rubino is the founder and Director of the Washington Center for Weight Management & Research in Arlington, VA, USA, a comprehensive weight management programme utilising a multidisciplinary team for the care of the individuals with obesity.
Dr Rubino is board certified in Obesity Medicine, Endocrinology, Diabetes & Metabolism, and Internal Medicine and received training in both clinical and molecular biological research at the US National Institutes of Health. She is currently a clinical investigator for AstraZeneca, Boehringer Ingelheim and Novo Nordisk, and is the recipient of an independent research grant from Obesinov, SARL.
She currently serves as a clinical expert on the treatment of obesity for several professional committees, and as a consultant and speaker for Novo Nordisk, and has also served as a representative to Congress and outside organisations for The Obesity Society.
Dr Rubino has received several investigator awards, and has written articles in peer-reviewed publications (including Obesity, the European Journal of Endocrinology, the Journal of Clinical Endocrinology and Metabolism and Diabetes, Obesity and Metabolism), and recently contributed a chapter on ‘Biopsychosocial Modifiers of Obesity’ for the textbook entitled Bariatric Endocrinology, published by Springer Verlag.